Literature DB >> 17785963

Chronic liver abnormalities in sickle cell disease: a clinicopathological study in 70 living patients.

Fabiola Traina1, Stefano Gonçalves Jorge, Ademar Yamanaka, Luciana R de Meirelles, Fernando Ferreira Costa, Sara T O Saad.   

Abstract

BACKGROUND AND AIM: The present study aimed to evaluate the incidence and etiology of chronic liver abnormalities in 70 living patients with sickle cell disease from the Hematology and Hemotherapy Center of the State University of Campinas.
METHODS: Clinical and laboratory investigations, including liver function tests, serological tests for viral hepatitis and abdominal ultrasound, were performed in all patients. Additionally, liver biopsies were taken from 20 patients.
RESULTS: Sixty-seven (96%) patients had some liver abnormality; these included abnormal liver function tests, viral hepatitis, liver ultrasonographic changes or cholelithiasis. The sickling process was the only explanation for the abnormal liver function tests or liver ultrasonographic changes in 24% of these patients. One or more defined reasons, including viral hepatitis, cholelithiasis, clinical hemosiderosis, alcoholism or diabetes, justified the liver abnormalities in 76% of the patients. Nineteen of the 20 liver biopsies presented some degree of vascular lesion; other histological findings were associated with hemosiderosis, viral hepatitis or cholestasis.
CONCLUSIONS: In patients with sickle cell disease, chronic liver abnormalities are frequent and seem to be a multifactorial phenomenon, depending on overlapping factors such as cholelithiasis, viral damage, iron overload and also the primary disease itself. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17785963     DOI: 10.1159/000107744

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

1.  Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen.

Authors:  Hana A Qhalib; Gamal H Zain
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

2.  Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy.

Authors:  Angela Siciliano; Giorgio Malpeli; Orah S Platt; Christophe Lebouef; Anne Janin; Aldo Scarpa; Oliviero Olivieri; Eliana Amato; Roberto Corrocher; Yves Beuzard; Lucia De Franceschi
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

3.  Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ Thalassemia) without Other Known Causes of Hepatic Disease.

Authors:  Luca Santi; Giancarlo Montanari; Sonia Berardi; Corrado Patti; Marta Frigerio; Claudia Sama; Paolo Caraceni; Mauro Bernardi
Journal:  Case Rep Gastroenterol       Date:  2009-09-12

4.  Liver Transplantation in Patients with Sickle Cell Disease in the United States.

Authors:  Rachel Hogen; Michelle Kim; Yelim Lee; Mary Lo; Navpreet Kaur; Jeff Kahn; Shefali Chopra; Yasir Qazi; Ashraf Sedra; Jim Kim; Lauren O'Brien; Yuri Genyk; Linda Sher; Juliet Emamaullee
Journal:  J Surg Res       Date:  2020-06-12       Impact factor: 2.192

5.  Marked Direct Hyperbilirubinemia due to Ceftriaxone in an Adult with Sickle Cell Disease.

Authors:  Daniyeh Khurram; Leonid Shamban; Robert Kornas; Maryann Paul
Journal:  Case Rep Gastrointest Med       Date:  2015-05-25

6.  Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature.

Authors:  Morey A Blinder; B Geng; Mauricio Lisker-Melman; Jeffrey S Crippin; Kevin Korenblat; William Chapman; Shalini Shenoy; Joshua J Field
Journal:  Hematol Rep       Date:  2013-05-02

7.  Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease.

Authors:  Magda Oliveira Seixas Carvalho; André Luís Carvalho Santos Souza; Mauricio Batista Carvalho; Ana Paula Almeida Souza Pacheco; Larissa Carneiro Rocha; Valma Maria Lopes do Nascimento; Camylla Vilas Boas Figueiredo; Caroline Conceição Guarda; Rayra Pereira Santiago; Adekunle Adekile; Marilda de Souza Goncalves
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

8.  Effect of N(Epsilon)-(carboxymethyl)lysine on Laboratory Parameters and Its Association with β S Haplotype in Children with Sickle Cell Anemia.

Authors:  Uche Samuel Ndidi; Corynne Stephanie Ahouefa Adanho; Rayra Pereira Santiago; Sètondji Cocou Modeste Alexandre Yahouédéhou; Sânzio Silva Santana; Vitor Valério Mafili; Thassila Nogueira Pitanga; Cleverson Alves Fonseca; Junia Raquel Dutra Ferreira; Elisângela Vitoria Adorno; Isa Menezes Lyra; Adekunle D Adekile; Cynara Gomes Barbosa; Marilda Souza Goncalves
Journal:  Dis Markers       Date:  2019-09-15       Impact factor: 3.434

9.  Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.

Authors:  Arianna Barbetta; Cameron Goldbeck; Angelina Lim; Sean P Martin; Jeffrey A Kahn; M Raashid Sheikh; Juliet Emamaullee
Journal:  HPB (Oxford)       Date:  2021-07-06       Impact factor: 3.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.